88 related articles for article (PubMed ID: 17443844)
1. Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A.
Cecconi D; Donadelli M; Rinalducci S; Zolla L; Scupoli MT; Scarpa A; Palmieri M; Righetti PG
Proteomics; 2007 May; 7(10):1644-53. PubMed ID: 17443844
[TBL] [Abstract][Full Text] [Related]
2. SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines.
Ryu JK; Lee WJ; Lee KH; Hwang JH; Kim YT; Yoon YB; Kim CY
Cancer Lett; 2006 Jun; 237(1):143-54. PubMed ID: 16009488
[TBL] [Abstract][Full Text] [Related]
3. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.
Wetzel M; Premkumar DR; Arnold B; Pollack IF
J Neurosurg; 2005 Dec; 103(6 Suppl):549-56. PubMed ID: 16383255
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
Baradari V; Huether A; Höpfner M; Schuppan D; Scherübl H
Endocr Relat Cancer; 2006 Dec; 13(4):1237-50. PubMed ID: 17158768
[TBL] [Abstract][Full Text] [Related]
5. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells.
Donadelli M; Costanzo C; Faggioli L; Scupoli MT; Moore PS; Bassi C; Scarpa A; Palmieri M
Mol Carcinog; 2003 Oct; 38(2):59-69. PubMed ID: 14502645
[TBL] [Abstract][Full Text] [Related]
6. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of apoptosis induced by trichostatin A in leukemia Molt-4 cells analyzed by microarray].
Hong ZY; Yi LS; Miao XY; Lu YP; Zhou JF; Liu WL
Ai Zheng; 2006 Aug; 25(8):946-53. PubMed ID: 16965673
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study on the effect of trichostatin A on differentiation of human lung carcinoma cell].
Wang CT; Meng M
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):927-9. PubMed ID: 17650409
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis identifies protein targets responsible for depsipeptide sensitivity in tumor cells.
Chen G; Li A; Zhao M; Gao Y; Zhou T; Xu Y; Du Z; Zhang X; Yu X
J Proteome Res; 2008 Jul; 7(7):2733-42. PubMed ID: 18549279
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study.
Cecconi D; Donadelli M; Dalla Pozza E; Rinalducci S; Zolla L; Scupoli MT; Righetti PG; Scarpa A; Palmieri M
Proteomics; 2009 Apr; 9(7):1952-66. PubMed ID: 19294695
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera.
Sasaki K; Yamagata T; Mitani K
Cancer Sci; 2008 Feb; 99(2):414-22. PubMed ID: 18271940
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor trichostatin A induced caspase-independent apoptosis in human gastric cancer cell.
Wu ZQ; Zhang R; Chao C; Zhang JF; Zhang YQ
Chin Med J (Engl); 2007 Dec; 120(23):2112-8. PubMed ID: 18167185
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.
Khaw AK; Silasudjana M; Banerjee B; Suzuki M; Baskar R; Hande MP
Mutat Res; 2007 Dec; 625(1-2):134-44. PubMed ID: 17669439
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid.
Tong A; Zhang H; Li Z; Gou L; Wang Z; Wei H; Tang M; Liang S; Chen L; Huang C; Wei Y
Cancer Chemother Pharmacol; 2008 Apr; 61(5):791-802. PubMed ID: 17593366
[TBL] [Abstract][Full Text] [Related]
17. Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells.
Nakamura C; Matsushita I; Kosaka E; Kondo T; Kimura T
Rheumatology (Oxford); 2008 Apr; 47(4):418-24. PubMed ID: 18281366
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma.
Dalgard CL; Van Quill KR; O'Brien JM
Clin Cancer Res; 2008 May; 14(10):3113-23. PubMed ID: 18483379
[TBL] [Abstract][Full Text] [Related]
19. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMullan C; Miller JW; Marks PA; Mitsiades N
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4072-9. PubMed ID: 19387079
[TBL] [Abstract][Full Text] [Related]
20. Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3.
Zhang S; Cai X; Huang F; Zhong W; Yu Z
Exp Oncol; 2008 Dec; 30(4):265-8. PubMed ID: 19112422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
